ULSUL Solutions Inc.
Services-Testing Laboratories
- Revenue
- $3.1B
- 6.4% YoY
- Operating margin
- 17.1%
- 6.2% YoY
- EBITDA
- $710M
- 12% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 0.1×
- $57M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear185% of net incomeCash flow under 80% of net income
- Dilutive SBCClear2% of revenueOver 10% of revenue
- Payouts exceed cash flowClear17% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear21% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|
| Revenue | $2.5B | $2.7B | $2.9B | $3.1B | 6.4% |
| Operating income | $412M | $368M | $462M | $522M | 13% |
| Net income | $293M | $260M | $326M | $325M | 0.3% |
| Operating cash flow | $372M | $467M | $524M | $600M | 15% |
| Capex | $164M | $215M | $237M | $197M | 17% |
| Stock-based comp | $0 | $0 | $23M | $47M | 104% |
| Dividends | $1.6B | $680M | $100M | $104M | 4.0% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $876K · 1
- Net
- −$876K
Pay vs performance
No pay-versus-performance disclosure yet.